Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis
Open Access
- 13 July 2012
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 19 (12) , 1992-2002
Abstract
The tumor-suppressor p53 can induce various biological responses. Yet, it is not clear whether it is p53 in vivo promoter selectivity that triggers different transcription programs leading to different outcomes. Our analysis of genome-wide chromatin occupancy by p53 using chromatin immunoprecipitation (ChIP)-seq revealed ‘p53 default program’, that is, the pattern of major p53-bound sites that is similar upon p53 activation by nutlin3a, reactivation of p53 and induction of tumor cell apoptosis (RITA) or 5-fluorouracil in breast cancer cells, despite different biological outcomes. Parallel analysis of gene expression allowed identification of 280 novel p53 target genes, including p53-repressed AURKA. We identified Sp1 as one of the p53 modulators, which confer specificity to p53-mediated transcriptional response upon RITA. Further, we found that STAT3 antagonizes p53-mediated repression of a subset of genes, including AURKA.Keywords
This publication has 38 references indexed in Scilit:
- Therapeutic potential of Aurora kinase inhibitors in cancer.2006
- Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2−p53 InteractionJournal of Medicinal Chemistry, 2006
- Composite Module Analyst: a fitness-based tool for identification of transcription factor binding site combinationsBioinformatics, 2006
- A Global Map of p53 Transcription-Factor Binding Sites in the Human GenomeCell, 2006
- Transcription Factor Interactions and Chromatin Modifications Associated with p53-Mediated, Developmental Repression of the Alpha-Fetoprotein GeneMolecular and Cellular Biology, 2005
- Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumorsNature Medicine, 2004
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2Science, 2004
- Mechanisms of apoptosis induction by nucleoside analogsOncogene, 2003
- Synergistic transcriptional activation of the MCK promoter by p53: tetramers link separated DNA response elements by DNA loopingOncogene, 1998
- Fitting a mixture model by expectation maximization to discover motifs in biopolymers.1994